의료 예측 분석용 인공지능(AI) 시장 - 전략적 인사이트와 예측(2026-2031년)

The Artificial Intelligence (AI) in Predictive Healthcare Analytics market is forecast to grow at a CAGR of 42.7%, reaching USD 62.1 billion in 2031 from USD 10.5 billion in 2026.

The Artificial Intelligence in predictive healthcare analytics market is strategically positioned at the intersection of digital health, big data, and clinical decision support. Healthcare systems are under pressure to improve outcomes while controlling costs. Predictive analytics powered by AI enables early risk identification, personalized treatment planning, and optimized resource utilization. Macro drivers include rising chronic disease burden, aging populations, and the shift toward value-based care models. Hospitals and healthcare providers are increasingly integrating data-driven tools into operational and clinical workflows. This positions the market as a core component of next-generation healthcare infrastructure.

Market Drivers

The primary growth driver is the expanding volume of healthcare data generated from electronic health records, medical imaging, and wearable devices. AI-based analytics solutions convert this data into actionable insights for disease prediction and care management. Another key driver is the demand for early diagnosis and preventive healthcare. Predictive models help clinicians identify high-risk patients and intervene before complications arise. Government initiatives supporting digital health adoption also stimulate market growth. Investments in healthcare IT infrastructure and cloud-based platforms further support large-scale deployment. In addition, the need to reduce hospital readmissions and improve operational efficiency encourages adoption of predictive analytics tools across care settings.

Market Restraints

Data privacy and security concerns remain major barriers to adoption. Healthcare data is highly sensitive, and regulatory compliance requirements increase implementation complexity. High costs associated with AI software integration and system customization limit adoption among smaller healthcare facilities. Limited availability of skilled professionals in data science and clinical informatics slows deployment. Interoperability challenges between legacy systems and new AI platforms restrict seamless data exchange. Ethical concerns related to algorithm transparency and bias also affect user trust and regulatory acceptance.

Technology and Segment Insights

The market can be segmented by component, application, and end user. By component, solutions include software platforms and associated services such as system integration and support. Software dominates due to continuous algorithm development and analytics upgrades. By application, key segments include disease prediction, population health management, hospital workflow optimization, and clinical decision support. Disease risk prediction and patient monitoring account for significant market share due to their direct impact on treatment outcomes. End users include hospitals, clinics, diagnostic centers, and research institutions. Hospitals represent the largest segment because of high patient volumes and strong demand for operational efficiency tools. Cloud-based deployment is gaining traction due to scalability and lower infrastructure costs compared to on-premise systems.

Competitive and Strategic Outlook

The competitive landscape is shaped by technology companies, healthcare IT providers, and analytics specialists. Strategic focus areas include improving model accuracy, expanding clinical use cases, and forming partnerships with healthcare providers. Companies are investing in compliance frameworks to address regulatory requirements and data security risks. Product differentiation is driven by integration capabilities with existing hospital information systems and electronic health records. Regional expansion strategies target markets with strong healthcare digitization and supportive regulatory environments. Mergers and collaborations are used to enhance data access and analytics expertise.

The Artificial Intelligence in predictive healthcare analytics market is entering a phase of rapid commercialization. Growth is supported by digital health adoption and the need for proactive care models. While data security and cost challenges remain, continuous innovation and policy support are expected to sustain strong market expansion through 2031.

Key Benefits of this Report

• Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base Year 2025, Forecast Years 2026-2031
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY DEPLOYMENT MODE

• 5.1. Introduction
• 5.2. Cloud-Based
• 5.3. On-Premise

6. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Patient Risk Stratification
• 6.3. Disease Diagnosis And Prognosis
• 6.4. Population Health Management
• 6.5. Fraud Detection
• 6.6. Supply Chain Management
• 6.7. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals And Clinics
• 7.3. Healthcare Payers
• 7.4. Pharmaceutical And Biotechnology Companies
• 7.5. Research Institutes And Academic Centers
• 7.6. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN PREDICTIVE HEALTHCARE ANALYTICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Deployment Mode
  • 8.2.2. By Application
  • 8.2.3. BY End-User
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Deployment Mode
  • 8.3.2. By Application
  • 8.3.3. BY End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Deployment Mode
  • 8.4.2. By Application
  • 8.4.3. BY End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Italy
    • 8.4.4.5. Spain
    • 8.4.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Deployment Mode
  • 8.5.2. By Application
  • 8.5.3. BY End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Deployment Mode
  • 8.6.2. By Application
  • 8.6.3. BY End-User
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Taiwan
    • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Ibm Corporation
• 10.2. Microsoft Corporation
• 10.3. Google Llc (Alphabet Inc.)
• 10.4. Sas Institute Inc.
• 10.5. Oracle Corporation
• 10.6. Cerner Corporation
• 10.7. Allscripts Healthcare Solutions, Inc.
• 10.8. Medeanalytics, Inc.
• 10.9. Ayasdi, Inc.
• 10.10. Health Catalyst, Inc.